Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Vaccines news

Show

From To
Vaccines
HIV inner shell structure revealed

Researchers have for the first time unravelled the complex structure of the inner protein shell of the HIV molecule.

Published
30 May 2013
From
BBC Health
Vaccines
'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Published
20 May 2013
From
FRANCE 24
Vaccines
Competing antibodies may have limited the protection achieved in HIV vaccine trial in Thailand

Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.

Published
17 May 2013
From
Eurekalert Inf Dis
Cancer
Cancer Vaccines Get a Price Cut in Poor Nations

The two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world’s poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major deadly cancer.

Published
14 May 2013
From
New York Times
Vaccines
New tool for identifying powerful HIV antibodies

A team of NIH scientists has developed a new tool to identify broadly neutralizing antibodies (bNAbs) capable of preventing infection by the majority of HIV strains found around the globe, an advance that could help speed HIV vaccine development.

Published
10 May 2013
From
Science Daily
Vaccines
AIDS vaccine trial results, while disappointing, must guide continuing search

"This trial has provided a clear, swift answer about a specific vaccine strategy. It's not the answer we hoped for, but the search doesn't end here. There are other approaches that must be pursued without delay, and this result will help to focus and guide research efforts," said Mitchell Warren, AVAC executive director.

Published
26 April 2013
From
AVAC press release
Vaccines
NIH Discontinues Immunizations in HIV Vaccine Study

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor reduce viral load (the amount of HIV in the blood) among vaccine recipients who became infected with HIV.

Published
25 April 2013
From
National Institute of Allergy and Infectious Diseases (NIAID) press release
Sexually transmitted infections
HPV Vaccine Showing Successes in Australia

The US government’s goal of vaccinating young girls against the human papillomavirus has been disappointing, with less than a third of teenagers having completed a full course of HPV vaccine. But now the United States can look to Australia, which six years into a successful nationwide HPV vaccination campaign has experienced a sharp decline in the number of new cases of genital warts among young men and women.

Published
19 April 2013
From
New York Times
Vaccines
Study Points to Possible Path to AIDS Vaccine

In what may be an important step toward a long-elusive AIDS vaccine, American researchers have minutely tracked one person’s powerful immune response to the virus to see how a series of mutations led to an antibody that can defeat many H.I.V. strains. A vaccine still remains far off, but the research lighted up one complex path that may someday be followed to that distant goal.

Published
04 April 2013
From
New York Times
Vaccines
Researchers see antibody evolve against HIV

For the first time, scientists have tracked in a patient the evolution of a potent immune molecule that recognizes many different HIV viruses. By revealing how these molecules — called broadly neutralizing antibodies — develop, the research could inform efforts to make vaccines that elicit similar antibodies that can protect people from becoming infected with HIV.

Published
04 April 2013
From
Nature
← First12345...14Next →

Filter by country